VarmX raises €30M to develop therapeutic proteins that restore hemostasis in bleeding patients
VarmX aims to develop and manufacture therapeutic proteins to restore hemostasis.
VarmX aims to develop and manufacture therapeutic proteins to restore hemostasis.
DiogenX is a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes.
Xinvento is a biotech company focused on developing therapies for congenital hyperinsulinism (CHI).
Antiverse is building a computational antibody drug discovery platform. It combines machine learning and phage display techniques to model antibody-antigen ...
ExeVir Bio is a clinical stage biotechnology company developing nanobody based therapeutics focusing on infectious diseases.
Today, we bring you a list of Dutch-based biotech and life sciences startups that are changing the healthcare landscape and ...
ProQR is focused on the development of drugs to treat genetic disorders. Eli Lilly engages in the discovery, development, manufacture, ...
Anocca aims to develop a technological platform for studying T-cell biology in order to realise the therapeutic potential of T-cell ...
EnginZyme wants to play a key role in tackling climate change by enabling green chemistry for every industry.
London-based Bactobio, a biotechnology company, announced on Monday that it has secured £6M (approximately €6.9M) in an oversubscribed bridge financing ...
Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos
Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos